Lithium - adults - Depression
You are here : Home > Formulary Search > Lithium - adults - Depression
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
To be initiated by a specialist.
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the Blue information sheet and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Documentation
Information
PAD Profile
ChemicalSubstance :
Lithium - adults
Indication :
Depression
Group Name :
Keywords :
Brand Names Include :
Li-Liquid, Priadel
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Drugs
Below are listed other drugs that are used to treat Depression.
- Amitriptyline hydrochloride
- Bupropion hydrochloride
- Citalopram
- Clomipramine hydrochloride
- Duloxetine hydrochloride
- Escitalopram
- Esketamine hydrochloride
- Fluoxetine hydrochloride
- Flupentixol
- Fluvoxamine maleate
- Imipramine hydrochloride
- Isocarboxazid
- Lofepramine hydrochloride
- Mianserin hydrochloride
- Mirtazapine
- Moclobemide
- Nortriptyline
- Paroxetine hydrochloride
- Phenelzine sulfate
- Quetiapine
- Reboxetine
- Sertraline
- Tranylcypromine sulfate
- Trimipramine maleate
- Venlafaxine
- Vortioxetine
Committee Recommendations (1)
The Surrey & North West Sussex Area Prescribing Committee agreed the BLUE information sheet for lithium.